News

EU tariffs on Chinese electric cars based on WTO rules, Renault boss says

  • European Union tariffs imposed on Wednesday on imported Chinese electric vehicles are based on rules set by the World Trade Organization that everyone has signed up to, said Luca de Meo, chief executive of French car maker Renault.
    10/30/2024

UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency

  • NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) --  UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets, announced today that on October 10, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).
    10/17/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

UTime Limited (WTO) can sell. Click on Rating Page for detail.

The price of UTime Limited (WTO) is 0.287 and it was updated on 2025-01-14 13:00:48.

Currently UTime Limited (WTO) is in undervalued.

News
    
News

UTime Limited Announces Pricing of $5 Million Registered Direct Offering

  • NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets today announced that it has entered into a securities purchase agreement with certain accredited investor to sell $5 million of its ordinary shares in a registered direct offering.
    Fri, Sep. 13, 2024

Spain's Sánchez urges negotiated solution to China-EU trade tensions

  • Spanish Prime Minister Pedro Sánchez called for "a negotiated solution" at the World Trade Organisation (WTO) to end a stand-off between Beijing and the European Union...
    Tue, Sep. 10, 2024

Spain's Sánchez urges negotiated solution to China-EU trade tensions

  • Spanish Prime Minister Pedro Sánchez called for "a negotiated solution" at the World Trade Organisation (WTO) to end a stand-off between Beijing and the European Union...
    Tue, Sep. 10, 2024

UTime Limited Announces 1-For-25 Reverse Share Split

  • NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets today announced that it will effect a reverse share split of its outstanding ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), at a ratio of 1-for-25, to be effective on or around the open of trading on September 11, 2024.
    Mon, Sep. 09, 2024

Remarkable Announcement on Significant Fluctuation of the UTime's Share Price

  • SHENZHEN, China , Aug. 29, 2024 /PRNewswire/ --  Dear Investors, Analysts and Media: Recently, UTime Ltd ("UTime") has experienced a period of unusual share price volatility in the capital markets. As a responsible company, we understand the concerns of market participants about such situations and believe that it is necessary to provide the public with transparent and formalized information in this regard.
    Thu, Aug. 29, 2024
More Headlines
News

UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics

  • SHENZHEN, China , Aug. 29, 2024 /PRNewswire/ -- UTime Limited (NASDAQ:  WTO ) ("UTime" or the "Company"), which continues to build on its strengths in the global healthcare sector, has announced that it has commenced a comprehensive financial and legal due diligence on Bowen Therapeutics Inc ("Bowen Therapeutics"), which it intends to acquire. The move marks an important step in UTime's expansion of its presence in the field of innovative medical products, with the aim of strengthening its market position and advancing the future of medical technology.
  • 08/29/2024

UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines

  • SHENZHEN, China , Aug. 28, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") has officially announced the signing of a non-disclosure agreement (the "NDA") with Bowen Therapeutics Inc ("Bowen Therapeutics") for the acquisition of the Bowen Therapeutics laboratory at UMASS Medical School. This strategic move not only marks UTime's in-depth expansion in the global vaccine market, but also provides strong support for the registration of the relevant vaccine through the U.S. Food and Drug Administration (the "FDA").
  • 08/28/2024

About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron

  • SHENZHEN, China , Aug. 26, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is excited to announce its collaboration on Circul VS, a core continuous blood pressure measurement technology system developed in partnership with strategic partner, Dr. Ehud Baron. Designed to offer patients an accurate and user-friendly continuous blood pressure monitoring solution, Circul VS facilitates early detection and long-term management, helping to reduce the risks associated with cardiovascular and cerebrovascular conditions.
  • 08/26/2024

UTime Limited to Participate in International Medical Fairs and Medical Conferences

  • SHENZHEN, China , Aug. 23, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce its plans to participate in a series of internationally recognized medical fairs and medical conferences. These forthcoming events will provide a valuable opportunity for UTime to showcase its latest achievements in medical devices and solutions and to enhance its communication and partnerships within the global medical industry.
  • 08/23/2024

UTime Limited Announces Ambitious AI Health Strategy and Strategic Collaboration

  • SHENZHEN, China , Aug. 21, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce its ambitious strategy for advancing AI-driven health solutions. Recognizing the growing value and potential of smart health technologies, UTime is committing significant investments to expand its smart medical wearable products business.
  • 08/21/2024

UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions

  • SHENZHEN, China , Aug. 19, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce a Memorandum of Understanding ("MOU") with XCardio, a Japanese company owned by Dr. Ehud Baron, a leader in medical technology innovation. This partnership focuses on the joint development of state-of-the-art continuous blood pressure monitoring devices, BPWatch, aimed at advancing cardiovascular disease management.
  • 08/19/2024
Unlock
WTO Ratings Summary
WTO Quant Ranking